Unknown

Dataset Information

0

Hydrogen sulfide epigenetically mitigates bone loss through OPG/RANKL regulation during hyperhomocysteinemia in mice.


ABSTRACT: Hydrogen sulfide (H2S) is a novel gasotransmitter produced endogenously in mammalian cells, which works by mediating diverse physiological functions. An imbalance in H2S metabolism is associated with defective bone homeostasis. However, it is unknown whether H2S plays any epigenetic role in bone loss induced by hyperhomocysteinemia (HHcy). We demonstrate that diet-induced HHcy, a mouse model of metabolite induced osteoporosis, alters homocysteine metabolism by decreasing plasma levels of H2S. Treatment with NaHS (H2S donor), normalizes the plasma level of H2S and further alleviates HHcy induced trabecular bone loss and mechanical strength. Mechanistic studies have shown that DNMT1 expression is higher in the HHcy condition. The data show that activated phospho-JNK binds to the DNMT1 promoter and causes epigenetic DNA hyper-methylation of the OPG gene. This leads to activation of RANKL expression and mediates osteoclastogenesis. However, administration of NaHS could prevent HHcy induced bone loss. Therefore, H2S could be used as a novel therapy for HHcy mediated bone loss.

SUBMITTER: Behera J 

PROVIDER: S-EPMC6084464 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hydrogen sulfide epigenetically mitigates bone loss through OPG/RANKL regulation during hyperhomocysteinemia in mice.

Behera Jyotirmaya J   George Akash K AK   Voor Michael J MJ   Tyagi Suresh C SC   Tyagi Neetu N  

Bone 20180613


Hydrogen sulfide (H<sub>2</sub>S) is a novel gasotransmitter produced endogenously in mammalian cells, which works by mediating diverse physiological functions. An imbalance in H<sub>2</sub>S metabolism is associated with defective bone homeostasis. However, it is unknown whether H<sub>2</sub>S plays any epigenetic role in bone loss induced by hyperhomocysteinemia (HHcy). We demonstrate that diet-induced HHcy, a mouse model of metabolite induced osteoporosis, alters homocysteine metabolism by de  ...[more]

Similar Datasets

| S-EPMC8405081 | biostudies-literature
| S-EPMC3337833 | biostudies-literature
| S-EPMC4200779 | biostudies-literature
| S-EPMC4231117 | biostudies-literature
| S-EPMC7053481 | biostudies-literature
| S-EPMC8160801 | biostudies-literature
| S-EPMC5854893 | biostudies-literature
| S-EPMC6396498 | biostudies-literature
| S-EPMC5609750 | biostudies-literature
| S-EPMC7411003 | biostudies-literature